Developer of a science illustration software designed to empower the world to learn and communicate science through visuals. The company's platform permits scientists to create their compositions without any drawing, export their custom images in their preferred format and showcase their research, enabling scientists to quickly and easily communicate their research.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Provider of biopharmaceutical research services catering to pharmaceutical and biotechnology firms. The company offers clinical services from early- to late-stage clinical trial support that ranges from specialized staffing models to partnerships that oversee nearly all aspects of a drug program, thereby providing outsourced sales and consulting to its clients.
Morrisville, United StatesPharmaceuticals & Biotech
Disability:IN is a global nonprofit organization focused on advancing business disability inclusion. Founded in 2008 and based in Alexandria, VA, it aims to create an inclusive economy where people with disabilities can fully participate. The organization collaborates with a network of over 250-550 corporate partners and maintains alliances with various communities, including LGBTQ+, women, and people of color.
Disability:IN offers a range of services to promote disability inclusion in businesses. These include advisory and consulting services, data and insights through tools like the Disability Index®, and learning and development programs such as the NextGen Talent Accelerator. The organization also hosts networking events, annual conferences, and regional councils to foster collaboration and share best practices. Additionally, it runs a Supplier Diversity Program to connect Disability-Owned Business Enterprises with large corporations, enhancing contract opportunities and promoting inclusive hiring practices.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.